Announcements Trials
Browse Landscape

Status

Completed 55Unknown 22Recruiting 15Terminated 8Withdrawn 5Not yet recruiting 5Active not recruiting 5Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 25Observational 5

Sponsor

Cancer Type

Tumor-Agnostic 2Dermatologic 2Head & Neck 1

Conditions

Neoplasms 69Breast Neoplasms 68Prostatic Neoplasms 48Lung Neoplasms 34Carcinoma, Non-Small-Cell Lung 26Colorectal Neoplasms 19Pancreatic Neoplasms 17Carcinoma, Hepatocellular 16Brain Neoplasms 15Leukemia, Myeloid, Acute 14Lymphoma 13Colonic Neoplasms 13Carcinoma, Renal Cell 13Melanoma 12Head and Neck Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Ovarian Neoplasms 11Neoplasm Metastasis 10Lymphoma, Non-Hodgkin 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Multiple Myeloma 8Leukemia 8Glioblastoma 8Stomach Neoplasms 7Recurrence 7Papillomavirus Infections 7Hodgkin Disease 7

Interventions

Interviews as Topic 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × Observational × Carcinoma, Squamous Cell × Clear all
NCT04099446 2025-06-05

A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer

ProgenaBiome

Withdrawn
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms

NCT02750033 2018-08-20

Intraoperative Margin Assessment During Mohs Surgery

Seton Healthcare Family

Withdrawn
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT01148082 2017-06-26

School Response to Families Who Have Children With Cancer

Stanford University

Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell

NCT01484769 2017-04-10

H&N

University of Louisville

Withdrawn
Tumor-Agnostic

Carcinoma, Squamous Cell

NCT01075841 2014-07-02

A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck

Merck KGaA, Darmstadt, Germany

Withdrawn
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡